Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32165
Title: PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages.
Austin Authors: Schilperoort, Maaike;Ngai, David;Katerelos, Marina ;Power, David A ;Tabas, Ira
Affiliation: Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Nephrology
Institute for Breathing and Sleep
Medicine (University of Melbourne)
Issue Date: 16-Feb-2023
Date: 2023
Publication information: Nature Metabolism 2023; 5(3)
Abstract: Resolving-type macrophages prevent chronic inflammation by clearing apoptotic cells through efferocytosis. These macrophages are thought to rely mainly on oxidative phosphorylation, but emerging evidence suggests a possible link between efferocytosis and glycolysis. To gain further insight into this issue, we investigated molecular-cellular mechanisms involved in efferocytosis-induced macrophage glycolysis and its consequences. We found that efferocytosis promotes a transient increase in macrophage glycolysis that is dependent on rapid activation of the enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (PFKFB2), which distinguishes this process from glycolysis in pro-inflammatory macrophages. Mice transplanted with activation-defective PFKFB2 bone marrow and then subjected to dexamethasone-induced thymocyte apoptosis exhibit impaired thymic efferocytosis, increased thymic necrosis, and lower expression of the efferocytosis receptors MerTK and LRP1 on thymic macrophages compared with wild-type control mice. In vitro mechanistic studies revealed that glycolysis stimulated by the uptake of a first apoptotic cell promotes continual efferocytosis through lactate-mediated upregulation of MerTK and LRP1. Thus, efferocytosis-induced macrophage glycolysis represents a unique metabolic process that sustains continual efferocytosis in a lactate-dependent manner. The differentiation of this process from inflammatory macrophage glycolysis raises the possibility that it could be therapeutically enhanced to promote efferocytosis and resolution in chronic inflammatory diseases.
URI: https://ahro.austin.org.au/austinjspui/handle/1/32165
DOI: 10.1038/s42255-023-00736-8
ORCID: 0000-0002-8597-7675
0000-0003-3429-1515
Journal: Nature metabolism
PubMed URL: 36797420
ISSN: 2522-5812
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

38
checked on Nov 29, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.